Taz Harmon
Urology · Columbia, MONPI 1629074950
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for urology clinicians in MO, where the typical reported total is $4,012.
Across 179 payments — averaging $18.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$604
- Astellas Pharma US Inc$538
- Dendreon Pharmaceuticals LLC$196
- Pfizer$176
- Convatec Inc.$150
- Caldera Medical, Inc$127
- plus $1K from 31 others
What the payments were for
- Food & beverage$3,234100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 34 | $604 |
| Astellas Pharma US Inc | 35 | $538 |
| Dendreon Pharmaceuticals LLC | 9 | $196 |
| Pfizer | 11 | $176 |
| Convatec Inc. | 6 | $150 |
| Caldera Medical, Inc | 1 | $127 |
| Merck | 6 | $118 |
| Myovant Sciences Inc. | 6 | $116 |
| Amgen | 6 | $112 |
| Blue Earth Diagnostics | 5 | $86 |
| Travere Therapeutics, Inc. | 5 | $83 |
| AbbVie(2 entities) | 6 | $83 |
| Urovant Sciences Inc | 6 | $79 |
| Boston Scientific | 5 | $76 |
| Novartis | 4 | $70 |
| Antares Pharma, Inc. | 5 | $65 |
| Tolmar Pharmaceuticals, Inc. | 3 | $50 |
| Sanofi | 3 | $46 |
| Cook Medical LLC | 1 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $37 |
| Baxter Healthcare | 1 | $35 |
| Rochester Medical Corporation | 1 | $33 |
| Laborie Medical Technologies Corp. | 2 | $33 |
| Endo Pharmaceuticals Inc. | 2 | $32 |
| Progenics Pharmaceuticals, Inc. | 1 | $32 |
| Bayer | 2 | $30 |
| Axonics, Inc. | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $19 |
| Telix Pharmaceuticals | 1 | $18 |
| Neotract Inc. | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Tolmar, Inc. | 1 | $15 |
| Teleflex LLC | 1 | $15 |
| Halozyme Inc | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Dentsply IH Inc. | 1 | $14 |
| Clarus Therapeutics Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Desara$127
How this compares
$3,235 in reported general payments places this provider in the 45th percentile of 250 urology providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 11 | $36,300 |
| Tamsulosin Hcl | 45 | $888 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $363 |
| Finasteride | 11 | $262 |
Paid to pharmacies, not to this prescriber.
Other urology in Columbia
- Jack CampbellColumbia$54K
- Julie RileyColumbia$10K
- Travis BullockSaint Louis$201K
- Michael JohnsonSaint Louis$160K
- Samuel KuykendallKansas City$141K
- Gerald ParkNorth Kansas City$136K
- Gurdarshan SandhuSaint Louis$101K
- Etai GoldenbergSt. Louis$95K
- Gregory McLennanSaint Louis$89K
- Majdee IslamSaint Peters$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.